Jing Wang

Ms. Jing Wang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
YFYaling Feng
Yaling Feng
ZHZhigang Hou
Zhigang Hou
YLYuzhong Lu
Yuzhong Lu
HCHuihong Chen
Huihong Chen
MWMengna Wu
Mengna Wu
This study aims to investigate healthcare workers’ (HCWs) willingness to receive SARS-CoV-2 vaccine in Zhejiang and to discover the related influential factors. The survey was conducted in six regions of Zhejiang Province, China, and 13 hospitals and 12 Centers for Disease Control and Prevention (CDC) were incorporated into the survey research. Participants were healthcare workers and a total of 3726 questionnaires were collected online, of which 3634 (97.53%) were analyzed. The relationships between the factors and the willingness to get vaccinated against COVID-19 were computed as odds ratios (ORs) by means of multi-factor non-conditional logistic regression analysis. Of the 3634 participants, 2874 (79.09%) HCWs expressed their willingness to get vaccinated if the SARS-CoV-2 vaccine becomes available. Respondents who were younger than 50 years (OR = 1.502, 95% CI: 1.047–2.154), those who believed that they were somewhat likely (OR = 1.658, 95% CI: 1.297–2.120) or likely (OR = 1.893, 95% CI: 1.334–2.684) to get infected by SARS-COV-2 and those with a positive attitude toward the SARS-CoV-2 vaccine were more willing to get vaccinated. Furthermore, compared to doctors, nurses were more reluctant to get vaccinated. In addition, it was found that higher the education level, lower the willingness to get vaccinated. This study revealed that HCWs in Zhejiang Province had a high willingness to get vaccinated. Awareness about the vaccine’s effectiveness and safety and the disease severity should be promoted among HCWs over 50 years of age and nurses to increase the willingness to get vaccinated.

6 December 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
JWJing Wang
Jing Wang
JDJian Du
Jian Du
YLYan Liu
Yan Liu
YXYuyang Xu
Yuyang Xu
JHJiayin Han
Jiayin Han
XZXuechao Zhang
Xuechao Zhang
Objectives: This study aimed to evaluate the safety profile of the recombinant zoster vaccine (RZV) after its marketing in China. Methods: We present a descriptive analysis and safety signal assessment of adverse events following immunization (AEFI) associated with RZV between September 2020 and December 2023. The descriptive data collected includes demographic characteristics and the classification of characteristics of AEFI cases, while vaccine safety signal assessment was evaluated using the reporting odds ratio (ROR). Results: In total, we documented 275 AEFI cases following RZV vaccination, with a reporting rate of 76.22/10,000 doses administered. Notably, only one case was classified as serious, and the reporting rates were significantly higher among females, individuals aged 50–59 years, and those residing in rural areas. Furthermore, the reporting rate for the first dose exceeded that for the second dose. Among the reported AEFI cases, 98.91% were attributed to vaccine product-related reactions, and 97.45% were initially reported by either the vaccine recipient or their guardians. The interval between vaccination and symptom onset was predominant within 3 d after vaccination. The disproportionality analysis identified five positive signals—fever (37.5–38.5 °C), injection site reactions greater than 5 cm, pain, Henoch Schönlein purpura (HSP), and swelling—which suggests a stronger association with the RZV than the expected threshold. Conclusion: In summary, RZV demonstrated a favorable safety profile. However, continued monitoring and research on the long-term safety implications of RZV are needed.

25 May 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
JWJing Wang
Jing Wang
JDJian Du
Jian Du
YLYan Liu
Yan Liu
XCXinren Che
Xinren Che
YXYuyang Xu
Yuyang Xu
JHJiayin Han
Jiayin Han
With the widespread use of the 13-valent pneumonia vaccine (PCV13) in China, monitoring adverse events following immunization (AEFIs) is critical. We conducted a descriptive analysis of the AEFI occurrences reported within Hangzhou between the years 2020 and 2023, including the temporal trend of case reports and variables such as sex, age, type of PCV13, dose number, type of reporter, cause-specific classification, severity, and onset from vaccination. Vaccine safety signals were analyzed using reporting odds ratios (RORs). Over the 4 years analyzed in the study, 2564 AEFI cases were reported, including seven severe cases. Most AEFIs occurred within 0–1 days after vaccination (2398, 93.53%), with over half affecting infants aged 1.5–6 months of age. No statistically significant difference was observed between PCV13-TT and PCV-CRM197. Seasonal differences in AEFI reports were noted. Positive signals were detected for fever (ROR-1.96SE: 1.64) and persistent crying (ROR-1.96SE: 1.61). Four serious AEFI cases were coincidental events, while three others were considered vaccine-related cases (including one case each of allergic reaction, febrile seizure, and thrombocytopenia). The safety and tolerability of PCV13 are good, and attention should be paid to severe AEFIs, as well as long-term safety disparities between different types of PCV13.

20 November 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
ZLZhicai Liu
Zhicai Liu
JWJing Wang
Jing Wang
ZLZhaojun Lu
Zhaojun Lu
YXYuyang Xu
Yuyang Xu
JDJian Du
Jian Du
YLYan Liu
Yan Liu
Background: Immune thrombocytopenia (ITP) is an uncommon but serious adverse reaction after vaccination. However, its association with vaccines other than the measles–mumps–rubella vaccine remains debatable. This study aimed to analyze ITP cases following influenza vaccination and assess any potential association. Methods: We performed a systematic search of the Web of Science, Embase, and PubMed databases from their inception to 15 April 2024. Cases were characterized qualitatively, and relative risk was assessed using either fixed or random models. Results: A total of 24 studies were analyzed, including 16 patients from 14 case reports. Patients averaged 56.7 years old, half were female, and ten patients had a history of prior illness. The mean time between vaccination and diagnosis was 13.3 days. Treatment primarily involved corticosteroids or intravenous immunoglobulin, with most recovering within a month. The pooled odds ratio for ITP post-influenza vaccination was 0.94 (95%CI: 0.85–1.03). Subgroup analyses conducted according to the study design and vaccine type did not reveal any significant results. Conclusion: No evidence of an association between influenza vaccination and ITP was found. Further observational studies are required to verify this relationship.

26 May 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
JCJing Chen
Jing Chen
YLYanna Le
Yanna Le
HQHua Qin
Hua Qin
WYWanli Yang
Wanli Yang
XHXue Hu
Xue Hu
JWJing Wang
Jing Wang
Background: Animal-related injuries are a significant public health concern, particularly in urban settings with high population density and widespread pet ownership. Methods: This retrospective descriptive study was based on a clinic-based case series of animal-related injury presentations at a high-volume rabies vaccination clinic in Hangzhou, China, from 2015 to 2024. Demographic characteristics, injury site, exposure category, animal species, and time to presentation were extracted from outpatient records. Delayed presentation was defined as seeking care more than 3 days after injury. Descriptive analyses were performed to summarize clinic-based patterns. Multivariable logistic regression was used to identify factors associated with delayed presentation and to examine differences between dog- and cat-related injuries. Results: A total of 193,849 cases were included. Injuries exhibited significant seasonality, with the highest incidence in summer (30.16%) and the lowest in winter (20.22%). Females accounted for 55.9% of cases, and the 16–30 age group was the most affected (36.2%). Upper extremities were the predominant injury site (61.1%), and most cases were WHO Category II exposures (83.8%). Domestic animals caused 82.5% of injuries, with dogs (65.85%) and cats (27.64%) being the main offending animals. The rate of delayed presentation (>3 days) increased from 10.48% in 2015 to a peak of 20.67% in 2019 and then stabilized at approximately 16%. Multivariable logistic regression analysis showed that both Category I and Category III exposures (compared with Category II), injuries caused by non-dog species, and injuries caused by non-domestic animals were associated with higher odds of delayed presentation, while younger individuals and those with head and face injuries were less likely to delay care-seeking. For cat-related injuries (vs. dog-related injuries), independent predictors included increasing age, female sex, head and face injuries, and Category III exposure. Conclusion: This study provides a comprehensive description of animal-related injury presentations at a major urban rabies vaccination clinic. The findings highlight variation in healthcare-seeking behavior and injury patterns across demographic and exposure characteristics. These results may inform future hypothesis-driven research and support the development of targeted public health education strategies.

23 April 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
ZHZhaokai He
Zhaokai He
MLMinchao Li
Minchao Li
YZYun Zeng
Yun Zeng
RZRui Zhang
Rui Zhang
JTJing Tao
Jing Tao
JWJing Wang
Jing Wang
Objective: This study assessed the influence of a highly publicized influenza-related death event on caregivers’ influenza vaccination intention for kindergarten and primary school children in Zhejiang, China, and identified associated factors. Methods: A cross-sectional survey was conducted from March to April 2025 using a multi-stage, stratified cluster sampling method across 10 districts/counties. Caregivers completed electronic questionnaires covering sociodemographics, event awareness, vaccination history, hesitancy, and cognitive attitudes. Factors associated with vaccination intention were analyzed using chi-square tests and logistic regression. Results: Among 2153 caregivers, overall vaccination intention for the 2025 season was 60.10%, markedly higher than the 2024 season’s actual rate (27.45%). Caregiver awareness of this event was 91.92%, primarily via social media (92.02%). In univariate analyses, event-related characteristics were significantly associated with vaccination intention: perceived “completely objective” coverage showed the highest willingness (79.68%, χ2 = 79.92, p < 0.001), whereas the “exaggerated risk” (52.44%) and “unaware” (51.15%) groups showed lower willingness. Exposure frequency also correlated positively: low exposure (0–2 times) had 53.39% willingness, moderate (3–5) 61.11%, and high (≥6) 66.10% (χ2 = 27.75, p < 0.001). However, stronger vaccination intention was independently associated with factors such as no prior vaccination refusal [aOR(95% CI) = 2.74(2.03,3.72)] or hesitancy history [1.47(1.13,1.92)], greater information need (aOR = 6.42–8.83), and disbelief in influenza’s spontaneous resolution [1.39(1.08,1.77)]. Weaker intention was associated with poorer child health status [0.19(0.04,0.74)], no influenza vaccination in 2024 [0.41(0.30,0.55)], no influenza illness in 2024 [0.73(0.56,0.95)], belief in vaccine protection [0.60(0.46,0.79)], and the perception that most parents have their children vaccinated [0.70(0.53,0.93)]. Conclusions: Following a highly publicized celebrity influenza death, vaccination intention was primarily driven by caregivers’ cognitive, psychological, and behavioral experience factors. Caregivers who perceived event coverage as completely objective showed higher vaccination intention, while prior vaccination behavior exhibited inertia. Targeted interventions should enhance information credibility and focus on previously unvaccinated and vaccine-hesitant groups to improve coverage.